Search - tctmd.com

Displaying 41 - 60 of 235

Sort: Relevancy | Date

Presentation TCT 2024

AltaValve TMVR System for Patients With Severe Mitral Regurgitation and Mitral Annular Calcification

Presenter: Tsuyoshi Kaneko

October 29, 2024

Presentation TCT 2024

Two-Year Outcomes Following Transseptal TMVR in the HighLife Feasibility Study: Hemodynamic Performance and Clinical Results

Presenter: Mirjam Keßler

October 29, 2024

Presentation TCT 2024

Primary Endpoint Results with the Second-Generation Cephea Transseptal TMVR System in Complex Mitral Valve Disease

Presenter: Pradeep Yadav

October 29, 2024

Presentation TCT 2024

Innovalve TMVR Facilitates LV Reverse Remodeling and Improvement in LV Function in Patients with Severe Mitral Regurgitation: Acute Results of the Innovalve TMVR TWIST-EFS and OUS Studies

Presenter: Steven Yakubov

October 29, 2024

Presentation TCT 2024

Reconciling Device Design and Clinical Need: How to Make TMVr Procedures Scalable and Reproducible?

Presenter: David Meerkin

October 29, 2024

Presentation TCT 2024

The Role of TMVR With Dedicated Devices in Patients With MAC: Initial Results and Ongoing Trials

Presenter: Paul Sorajja

October 29, 2024

Presentation TCT 2024

TCT 940: A Comparative Study of TENDYNE and Traditional Transcatheter Mitral Valve Implantation on Reverse Remodeling and Outcome

Presenter: Chong Bin Lee

October 29, 2024

Presentation TCT 2024

TCT 947: AltaValve Atrial Fixation System for Treatment of Severe Atrial Functional Mitral Regurgitation

Presenter: John Saxon

October 29, 2024

Presentation TCT 2024

TCT 944: Left Ventricular Outflow Tract Impact on Transcatheter Mitral Valve Interventions

Presenter: Nicholas Sturla

October 29, 2024

Presentation TCT 2024

TCT 941: Addressing Anatomical Challenges to Transcatheter Mitral Valve Replacement With the Transseptal Highlife TMVR System

Presenter: Thomas Waggoner

October 29, 2024

Presentation TCT 2024

TCT 943: Durable Valve Prosthesis Performance and Sustained Symptom Relief: 2-Year Outcomes Following Transseptal Transcatheter Mitral Valve Replacement in the HighLife TSMVR Feasibility Study

Presenter: Mirjam Keßler

October 29, 2024

Presentation TCT 2024

TCT 946: Left Ventricular Volume Predicts In-Hospital Outcome in Tendyne™ Patients

Presenter: Liliane Zillner

October 29, 2024

Presentation TCT 2024

TCT 945: AltaValve System TMVR for the Treatment of Patients With Severe Mitral Regurgitation and Mitral Annular Calcification

Presenter: Tsuyoshi Kaneko

October 29, 2024

Presentation TCT 2024

TCT 1147: Transfemoral Valve in MAC TMVR With a Balloon Expandable Prosthesis and Balloon Assisted Translocation of the Anterior Mitral Valve Leaflet (BATMAN)

Presenter: Vlasis Ninios

October 28, 2024

Presentation TCT 2024

Can Future TMVR Systems Fulfill Their Promise in the MR Marketplace?

Presenter: Bill Shields

October 27, 2024

News Conference News TCT 2023

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

Yael L. Maxwell

October 30, 2023

$TCT 752: Combined valvular and subvalvular intervention with Innovalve TMVR facilitates reverse remodeling and improves left ventricular ejection fraction in patients with severe chronic mitral regurgitation$

Presentation TCT 2023

TCT 752: Combined valvular and subvalvular intervention with Innovalve TMVR facilitates reverse remodeling and improves left ventricular ejection fraction in patients with severe chronic mitral regurgitation (TWIST-EFS and FIH studies)

Presenter: Chet Rihal

October 26, 2023

Presentation TCT 2023

TCT 748: Innovalve TMVR clinical data from TWIST-EFS and FIH studies

Presenter: Chet Rihal

October 26, 2023

Presentation TCT 2023

TCT 614: Successful treatment of MAC patients with atrial fixation TMVR device: The AltaValve

Presenter: Philippe Genereux

October 26, 2023

Presentation TCT 2023

TCT 498: AltaValve’s Unique Atrial Fixation is Designed to Overcome LVOT Obstruction Risk

Presenter: Vlassis Ninios

October 26, 2023

Advertisement

AltaValve TMVR System for Patients With Severe Mitral Regurgitation and Mitral Annular Calcification

Two-Year Outcomes Following Transseptal TMVR in the HighLife Feasibility Study: Hemodynamic Performance and Clinical Results

Primary Endpoint Results with the Second-Generation Cephea Transseptal TMVR System in Complex Mitral Valve Disease

Innovalve TMVR Facilitates LV Reverse Remodeling and Improvement in LV Function in Patients with Severe Mitral Regurgitation: Acute Results of the Innovalve TMVR TWIST-EFS and OUS Studies

Reconciling Device Design and Clinical Need: How to Make TMVr Procedures Scalable and Reproducible?

The Role of TMVR With Dedicated Devices in Patients With MAC: Initial Results and Ongoing Trials

TCT 940: A Comparative Study of TENDYNE and Traditional Transcatheter Mitral Valve Implantation on Reverse Remodeling and Outcome

TCT 947: AltaValve Atrial Fixation System for Treatment of Severe Atrial Functional Mitral Regurgitation

TCT 944: Left Ventricular Outflow Tract Impact on Transcatheter Mitral Valve Interventions

TCT 941: Addressing Anatomical Challenges to Transcatheter Mitral Valve Replacement With the Transseptal Highlife TMVR System

TCT 943: Durable Valve Prosthesis Performance and Sustained Symptom Relief: 2-Year Outcomes Following Transseptal Transcatheter Mitral Valve Replacement in the HighLife TSMVR Feasibility Study

TCT 946: Left Ventricular Volume Predicts In-Hospital Outcome in Tendyne™ Patients

TCT 945: AltaValve System TMVR for the Treatment of Patients With Severe Mitral Regurgitation and Mitral Annular Calcification

TCT 1147: Transfemoral Valve in MAC TMVR With a Balloon Expandable Prosthesis and Balloon Assisted Translocation of the Anterior Mitral Valve Leaflet (BATMAN)

Can Future TMVR Systems Fulfill Their Promise in the MR Marketplace?

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

TCT 752: Combined valvular and subvalvular intervention with Innovalve TMVR facilitates reverse remodeling and improves left ventricular ejection fraction in patients with severe chronic mitral regurgitation (TWIST-EFS and FIH studies)

TCT 748: Innovalve TMVR clinical data from TWIST-EFS and FIH studies

TCT 614: Successful treatment of MAC patients with atrial fixation TMVR device: The AltaValve

TCT 498: AltaValve’s Unique Atrial Fixation is Designed to Overcome LVOT Obstruction Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content